Ignite Creation Date:
2024-07-17 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470399
Status:
COMPLETED
Last Update Posted:
2024-06-24
First Post:
2024-06-17
Brief Title:
AI-Guided GenAIS TM Versus Standard Physician-Guided Dietary Supplementation for Managing Metabolic Syndrome
Sponsor:
SLAB SOLOWAYS
Organization:
SLAB SOLOWAYS
Study Overview
Official Title:
AI-Guided GenAIS TM Versus Standard Physician-Guided Dietary Supplementation for Managing Metabolic Syndrome A Randomized Controlled Study
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study AI-Guided GenAIS TM Versus Standard Physician-Guided Dietary Supplementation for Managing Metabolic Syndrome aimed to compare the effectiveness of AI-guided dietary supplement DS prescriptions versus standard physician-guided prescriptions in managing metabolic syndrome This 6-month randomized controlled trial included 160 participants diagnosed with metabolic syndrome Participants were divided into two groups one received DS based on physician judgment and the other based on GenAIS AI system analysis Primary outcomes focused on changes in metabolic parameters while secondary outcomes included individual components of metabolic syndrome inflammation levels body weight and adherence to the DS regimen Data collection involved genetic metabolic and clinical profiling with ethical considerations ensuring participant confidentiality and informed consent
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None